Autologous cell immunotherapy (IGV-001) with IGF-1R antisense oligonucleotide in newly diagnosed glioblastoma patients

Lee, I. Y., Hanft, S., Schulder, M., Judy, K. D., Wong, E. T., Elder, J. B., Evans, L. T., Zuccarello, M., Wu, J., Aulakh, S., Agarwal, V., Ramakrishna, R., Gill, B. J., Quiñones-Hinojosa, A., Brennan, C., Zacharia, B. E., Silva Correia, C. E., Diwanji, M., Pennock, G. K., … Boockvar, J. A. (2024). Autologous Cell Immunotherapy (IGV-001) with IGF-1R Antisense Oligonucleotide in Newly Diagnosed Glioblastoma Patients. Future Oncology, 20(10), 579–591. https://doi.org/10.2217/fon-2023-0702
Authors:
Ian Lee
Simon Hanft
Michael Schulder
Kevin Judy
Eric T. Wong
J. Bradley Elder
Linton T. Evans
Mario Zuccarello
Julian K. Wu
Sonikpreet Aulakh
Vijay Agarwal
Rohan Ramakrishna
Brian J.A. Gill
Alfredo Quiñones‐Hinojosa
Cameron Brennan
Brad E. Zacharia
Carlos Eduardo Silva Correia
Madhavi Diwanji
Gregory Pennock
Charles Scott
Raül Pérez‐Ollé
David W. Andrews
John A. Boockvar
Affiliated Authors:
Brian J.A. Gill
Subjects:
Author Keywords:
goldspire™
igv-001
antisense
autologous
glioblastoma
immunotherapy
radiation
temozolomide
Publication Type:
Article
Unique ID:
10.2217/fon-2023-0702
PMID:
Journal:
Publication Date:
Data Source:
OpenAlex

Record Created: